HIF1A and hepatocellular carcinoma: Inhibition of HIF-1α reversed the effect(s) of virus glycoproteins and infection on hepatoma migration and significantly reduced HCV replication, demonstrating a dual role for HIF-1α in deregulating cellular processes associated with tumor growth and in the viral life cycle.